´ëÇѾÏÇÐȸ AACR-KCA Joint Workshop on Precision Medicine ¹× Á¦23Â÷ ´ëÇѾÏÇÐȸ Ãß°è½ÉÆ÷Áö¾ö 2 : 2019-11-15±³À°ÀÏÀÚ : 2019-11-15
±³À°Àå¼Ò : ¼¿ï·Ôµ¥È£ÅÚ 2Ãþ Crystal Ballroom èâ 4°³·ë
±³À°ÁÖÁ¦ :
AACR-KCA Joint Workshop on Precision Medicine ¹× Á¦23Â÷ ´ëÇѾÏÇÐȸ Ãß°è½ÉÆ÷Áö¾ö 2ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 02-792-1486
À̸ÞÀÏ :
cancer4@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 19 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 350,000¿ø
ºñ°í 1. »çÀüµî·Ï: 1)ȸ¿ø(AACR ¶Ç´Â KCA): 15¸¸¿ø, 2)ºñȸ¿ø: 250,000¿ø, 3)Çлý,trainee: 10¸¸¿ø/ 2. ÇöÀåµî·Ï: 1)ȸ¿ø(AACR ¶Ç´Â KCA): 20¸¸¿ø, 2)ºñȸ¿ø: 300,000¿ø, 3)Trainee: 20¸¸¿ø, 4)Çлý: 15¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-15 Crystal Ballroom 09:00~09:25 To be announced Luis A. Diaz, Jr.(Memorial Sloan Kettering Cancer Center, New York, NY)
±³À°½Ã°£ 11-15 Crystal Ballroom 09:25~09:50 Tackling old targets by new immunologic strategies ¹Ú°æÈ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-15 Crystal Ballroom 09:50~10:15 Optimizing T cell receptor gene therapy for cancer Aude G. Chapuis(Fred Hutchinson Cancer Research Center, Portland, OR)
±³À°½Ã°£ 11-15 Crystal Ballroom 10:15~10:40 Heterogeneous T cell exhaustion in cancers and its implications in cancer immunotherapy ¹Ú¼öÇü(Çѱ¹°úÇбâ¼ú¿ø)
ÈÞ½Ä 11-15 10:40~10:55 Break ()
±³À°½Ã°£ 11-15 Crystal Ballroom 10:55~11:20 Is liver transplantation a treatment option in colorectal cancer patients with non-resectable liver only metastases? Svein Dueland(Oslo University Hospital, Oslo)
±³À°½Ã°£ 11-15 Crystal Ballroom 11:20~11:45 Breast cancer imaging: Beyond image data ¼º¸°æ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-15 Crystal Ballroom 11:45~12:10 To be announced Javid J. Moslehi(Vanderbilt University School of Medicine, Nashville, TN)
±³À°½Ã°£ 11-15 Crystal Ballroom 12:10~12:35 Recent updates of artificial intelligence in clinical oncology ±è³²±¹(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-15 Crystal Ballroom 12:45~13:25 RCC-Translate ¡®Best in Class¡¯ efficacy to foundational therapy Mauricio Monaco(MSD)
±³À°½Ã°£ 11-15 Sapphire Ballroom A 12:45~13:25 First-line osimertinib: Raising the bar for better outcomes in EGFR-mutant NSCLC ÇÑÁö¿¬(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 11-15 Crystal Ballroom 13:40~14:00 Performance evaluation of the National Cancer Screening Program in Korea Ãֱͼ±(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 11-15 Crystal Ballroom 14:00~14:20 Results of K-LUCAS and implementation of Korean lung cancer screening ±¸Áø¸ð(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-15 Crystal Ballroom 14:20~14:40 The reality and future task of national cervical cancer screening in Korea ¹Î°æÁø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-15 Crystal Ballroom 14:40~15:00 National colorectal cancer screening and pilot project in Korea ¼¹Î¾Æ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 11-15 Crystal Ballroom 15:00~15:20 Screening for prostate cancer: Moving evidence to recommendations ȲÀÇâ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-15 Emerald Room 13:40~14:05 Genetic evaluation of gynecological cancers ÀÓ¸íö(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 11-15 Emerald Room 14:05~14:30 Role of immunotherapy in gynecological cancers ±è°Ç¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-15 Emerald Room 14:30~14:55 Cytoreductive surgery for recurrent ovarian cancer in the era of target therapy Àå¼®ÁØ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 11-15 Emerald Room 14:55~15:20 Recent advances in the treatment of lymphedema ÀåÇÐ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom A 13:40~14:05 Function preserving surgery using sentinel lymph node navigation in gastric cancer ·ù±Ù¿ø(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 11-15 Sapphire Ballroom A 14:05~14:30 When is deferral of surgery justified in rectal cancer? ¹Ú¼±Áø(°æÈñÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom A 14:30~14:55 Laparoscopic gastrectomy for advanced gastric cancer ÇÑ»ó¿í(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom A 14:55~15:20 Minimally invasive surgery for recurrent colorectal cancer ±èÁø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom B 13:40~14:05 Modulation of radioresistance: Radiobiology meets immunology ±èÀξÆ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom B 14:05~14:30 Proton therapy experience in recurrent head and neck cancer ¹®¼ºÈ£(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 11-15 Sapphire Ballroom B 14:30~14:55 Experience of immunotherapy and salvage RT in recurrent lung cancer È«¼÷Èñ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom B 14:55~15:20 Advanced radiation treatment approaches for women ±è¿¬ÁÖ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 11-15 Belle-Vue Suite (36F) 14:00~15:00 Next-generation biomarker approaches for next-generation immunotherapeutics and combinations Leena Gandhi(Lilly)
ÈÞ½Ä 11-15 15:20~15:40 Break ()
±³À°½Ã°£ 11-15 Crystal Ballroom 15:40~16:05 Perioperative chemotherapy for gastric cancer °À±±¸(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-15 Crystal Ballroom 16:05~16:30 Perioperative radiotherapy in gastric cancer ±Ý¿õ¼·(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-15 Crystal Ballroom 16:30~16:55 Will the perioperative microbiota transformation change surgical and oncological outcomes? ÀÌÀαÔ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-15 Crystal Ballroom 16:55~17:20 Can perioperative chemotherapy omit perioperative radiotherapy? À̱ٿí(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-15 Emerald Room 15:40~16:10 An introduction of ARCHON (Advanced poRtal of Clinical History and multi-Omits iNformation) database È«µ¿¿Ï(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 11-15 Emerald Room 16:10~16:40 The necessity of Korean cancer genome databases ÁÖ¿µ¼®(Çѱ¹°úÇбâ¼ú¿ø)
±³À°½Ã°£ 11-15 Emerald Room 16:40~17:10 Benchmark database for QC and annotation in clinical panel sequencing ¼Õ´ë¼ø(ÇѸ²´ë)
Åä·Ð 11-15 Emerald Room 17:10~17:20 Q&A Discussion ()
±³À°½Ã°£ 11-15 Sapphire Ballroom A 15:40~16:05 Is three-dimensional imaging analysis useful for lung cancer surgery? ÀÌ⿵(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom A 16:05~16:30 Using advanced imaging technology to improve surgical outcome °ûÁ¤¸é(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom A 16:30~16:55 Oncoplastic surgery: What, when and for whom? °Å¿ì(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom A 16:55~17:20 Surgeons can be a prosumer ¹ÚÁؼ®(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom B 15:40~16:05 Role of pluripotency associated tranion factor on bladder carcinogenesis ½Åµ¿¸í(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom B 16:05~16:30 Functional surgical management of UCC Á¤º´Ã¢(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom B 16:30~16:55 Role of radiation therapy in UCC ±è¿µ¼®(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-15 Sapphire Ballroom B 16:55~17:20 Biology-driven systemic therapy for metastatic UCC ½Å»óÁØ(¿¬¼¼ÀÇ´ë)